Published in Nucleic Acids Res on July 25, 2007
Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence. Cell Host Microbe (2010) 1.76
The temporal response of the Mycobacterium tuberculosis gene regulatory network during growth arrest. Mol Syst Biol (2008) 1.56
High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. PLoS Pathog (2010) 1.45
Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2009) 1.38
Unusual diheme conformation of the heme-degrading protein from Mycobacterium tuberculosis. J Mol Biol (2009) 1.33
Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis. MBio (2014) 1.29
An anaerobic-type alpha-ketoglutarate ferredoxin oxidoreductase completes the oxidative tricarboxylic acid cycle of Mycobacterium tuberculosis. PLoS Pathog (2009) 1.11
Comprehensive insights into Mycobacterium tuberculosis DevR (DosR) regulon activation switch. Nucleic Acids Res (2011) 1.10
The transcriptional regulatory network of Mycobacterium tuberculosis. PLoS One (2011) 1.03
Arylamine N-acetyltransferases in mycobacteria. Curr Drug Metab (2008) 0.98
High-resolution transcriptome and genome-wide dynamics of RNA polymerase and NusA in Mycobacterium tuberculosis. Nucleic Acids Res (2012) 0.94
WXG100 protein superfamily consists of three subfamilies and exhibits an α-helical C-terminal conserved residue pattern. PLoS One (2014) 0.94
Function and regulation of class I ribonucleotide reductase-encoding genes in mycobacteria. J Bacteriol (2008) 0.94
The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis. PLoS Pathog (2014) 0.93
Long-range transcriptional control of an operon necessary for virulence-critical ESX-1 secretion in Mycobacterium tuberculosis. J Bacteriol (2012) 0.92
Evidence classification of high-throughput protocols and confidence integration in RegulonDB. Database (Oxford) (2013) 0.90
mosR, a novel transcriptional regulator of hypoxia and virulence in Mycobacterium tuberculosis. J Bacteriol (2009) 0.85
Binary particle swarm optimization for operon prediction. Nucleic Acids Res (2010) 0.84
Mycoplasma hyopneumoniae transcription unit organization: genome survey and prediction. DNA Res (2011) 0.84
The Psp system of Mycobacterium tuberculosis integrates envelope stress-sensing and envelope-preserving functions. Mol Microbiol (2015) 0.82
Revealing of Mycobacterium marinum transcriptome by RNA-seq. PLoS One (2013) 0.82
Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance. Antimicrob Agents Chemother (2015) 0.81
Functional analysis of an intergenic non-coding sequence within mce1 operon of M.tuberculosis. BMC Microbiol (2010) 0.81
Reannotation of translational start sites in the genome of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2012) 0.80
Integration of heterogeneous molecular networks to unravel gene-regulation in Mycobacterium tuberculosis. BMC Syst Biol (2014) 0.79
Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures. J Biol Chem (2013) 0.78
IpsA, a novel LacI-type regulator, is required for inositol-derived lipid formation in Corynebacteria and Mycobacteria. BMC Biol (2013) 0.78
Acid stress response of a mycobacterial proteome: insight from a gene ontology analysis. Int J Clin Exp Med (2009) 0.77
Mining genomic patterns in Mycobacterium tuberculosis H37Rv using a web server Tuber-Gene. Genomics Proteomics Bioinformatics (2011) 0.75
REMap: Operon map of M. tuberculosis based on RNA sequence data. Tuberculosis (Edinb) (2016) 0.75
Characterization of a novel heat shock protein (Hsp22.5) involved in the pathogenesis of Mycobacterium tuberculosis. J Bacteriol (2011) 0.75
The alr-groEL1 operon in Mycobacterium tuberculosis: an interplay of multiple regulatory elements. Sci Rep (2017) 0.75
Integration of Metabolic Modeling with Gene Co-expression Reveals Transcriptionally Programmed Reactions Explaining Robustness in Mycobacterium tuberculosis. Sci Rep (2016) 0.75
A versatile vector for mycobacterial protein production with a functional minimized acetamidase regulon. Protein Sci (2017) 0.75
Crosslinking of Dicyclotyrosine by the Cytochrome P450 Enzyme CYP121 from Mycobacterium tuberculosis Proceeds through a Catalytic Shunt Pathway. J Biol Chem (2017) 0.75
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med (2003) 7.99
Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci U S A (2001) 7.65
Operons in Escherichia coli: genomic analyses and predictions. Proc Natl Acad Sci U S A (2000) 5.79
RegulonDB (version 5.0): Escherichia coli K-12 transcriptional regulatory network, operon organization, and growth conditions. Nucleic Acids Res (2006) 5.57
Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology (2002) 5.17
A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology (1998) 4.97
A novel method for accurate operon predictions in all sequenced prokaryotes. Nucleic Acids Res (2005) 4.68
The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages. Mol Microbiol (2001) 4.60
ideR, An essential gene in mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response. Infect Immun (2002) 4.54
Prediction of operons in microbial genomes. Nucleic Acids Res (2001) 4.44
Using functional and organizational information to improve genome-wide computational prediction of transcription units on pathway-genome databases. Bioinformatics (2004) 3.58
Prediction of transcriptional terminators in Bacillus subtilis and related species. PLoS Comput Biol (2005) 2.54
Co-expression pattern from DNA microarray experiments as a tool for operon prediction. Nucleic Acids Res (2002) 2.50
A comparison of microarray databases. Brief Bioinform (2001) 2.06
Sigma factors and global gene regulation in Mycobacterium tuberculosis. J Bacteriol (2004) 2.05
Predicting the operon structure of Bacillus subtilis using operon length, intergene distance, and gene expression information. Pac Symp Biocomput (2004) 1.94
Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis (Edinb) (2004) 1.67
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2004) 1.64
The senX3-regX3 two-component regulatory system of Mycobacterium tuberculosis is required for virulence. Microbiology (2003) 1.62
A Bayesian network approach to operon prediction. Bioinformatics (2003) 1.57
Horizontal transfer of a virulence operon to the ancestor of Mycobacterium tuberculosis. Mol Biol Evol (2006) 1.46
Sigma factors of Mycobacterium tuberculosis. Tuber Lung Dis (1997) 1.40
Regulation of the Mycobacterium tuberculosis mce1 operon. J Bacteriol (2006) 1.37
Identification of some DNA damage-inducible genes of Mycobacterium tuberculosis: apparent lack of correlation with LexA binding. J Bacteriol (2001) 1.35
DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters. J Bacteriol (2002) 1.35
Transcriptional control of the mycobacterial embCAB operon by PknH through a regulatory protein, EmbR, in vivo. J Bacteriol (2006) 1.35
A mycobacterial operon essential for virulence in vivo and invasion and intracellular persistence in macrophages. Infect Immun (2006) 1.31
Transcription and autoregulation of the Rv3134c-devR-devS operon of Mycobacterium tuberculosis. Microbiology (2005) 1.27
The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology (1998) 1.27
DNA damage induction of recA in Mycobacterium tuberculosis independently of RecA and LexA. Mol Microbiol (2002) 1.23
Clusters of PE and PPE genes of Mycobacterium tuberculosis are organized in operons: evidence that PE Rv2431c is co-transcribed with PPE Rv2430c and their gene products interact with each other. FEBS Lett (2006) 1.20
mymA operon of Mycobacterium tuberculosis: its regulation and importance in the cell envelope. FEMS Microbiol Lett (2003) 1.20
The Mycobacterium tuberculosis Rv2358-furB operon is induced by zinc. Res Microbiol (2004) 1.19
Negative transcriptional regulation of the mce3 operon in Mycobacterium tuberculosis. Microbiology (2002) 1.15
The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis. Microbiology (2000) 1.13
Molecular evolutionary history of tubercle bacilli assessed by study of the polymorphic nucleotide within the nitrate reductase (narGHJI) operon promoter. J Clin Microbiol (2005) 1.10
Molecular analysis of Mycobacterium tuberculosis phosphate specific transport system in Mycobacterium smegmatis. Characterization of recombinant 38 kDa (PstS-1). Microb Pathog (2001) 1.00
Analysis of gene expression in operons of Streptomyces coelicolor. Genome Biol (2006) 0.98
Characterization of the two Mycobacterium tuberculosis recA promoters. J Bacteriol (2003) 0.96
The six mammalian cell entry proteins (Mce3A-F) encoded by the mce3 operon are expressed during in vitro growth of Mycobacterium tuberculosis. Scand J Immunol (2005) 0.87
Severe premature coronary artery disease with protease inhibitors. Lancet (1998) 5.59
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (1997) 5.55
Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (1996) 4.72
The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages. Mol Microbiol (2001) 4.60
Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med (1993) 3.34
Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet (2000) 3.06
Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut (1971) 2.75
Metabolism of Dibenzofuran by Pseudomonas sp. Strain HH69 and the Mixed Culture HH27. Appl Environ Microbiol (1990) 2.65
Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis (1993) 2.61
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
Cleavage of dibenzofuran and dibenzodioxin ring systems by a Pseudomonas bacterium. Naturwissenschaften (1989) 2.33
Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet (1998) 2.26
Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet (1981) 2.22
Mechanisms of cell death after pancreatic duct obstruction in the opossum and the rat. Gastroenterology (1996) 1.94
Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J Clin Microbiol (1990) 1.88
Long-term culture of murine epidermal keratinocytes. J Invest Dermatol (2000) 1.87
Indinavir concentrations and antiviral effect. Pharmacotherapy (1999) 1.82
Whole genome DNA microarray expression analysis of biofilm development by Vibrio cholerae O1 E1 Tor. Methods Enzymol (2001) 1.77
Five cases of alpha chain disease. Gut (1972) 1.75
Prospective audit of surgery for varicose veins. Br J Surg (1997) 1.73
Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med (1995) 1.70
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis (1997) 1.69
Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis (Edinb) (2004) 1.67
Prolymphocytic leukaemia. Br J Haematol (1974) 1.66
Evaluation and performance standards for arterial prostheses. J Vasc Surg (1993) 1.64
Reverse arterial blood flow as a pathway for central nervous system toxic responses following injection of local anesthetics. Anesth Analg (1978) 1.63
A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol (2006) 1.58
Late summer and fall (March-May) pollen allergy and respiratory disease in Northern New South Wales, Australia. Ann Allergy Asthma Immunol (2000) 1.57
Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology (1988) 1.57
Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res (2004) 1.57
Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol (1987) 1.54
Invasion and persistent intracellular colonization of erythrocytes. A unique parasitic strategy of the emerging pathogen Bartonella. J Exp Med (2001) 1.50
In vivo immune responses of mice during carcinogenesis by ultraviolet irradiation. J Natl Cancer Inst (1977) 1.47
Laser irradiation of tumours of the oesophagus and gastric cardia. Br Med J (Clin Res Ed) (1984) 1.45
A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol (2001) 1.43
Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med (1996) 1.43
Mac387: its non-specificity as a tumour marker or marker of histiocytes. Histopathology (1991) 1.43
A review of nearly two decades in an autologous blood programme: The rise and fall of activity. Transfus Med (2006) 1.42
Variables influencing worker compliance with universal precautions in the emergency department. Am J Infect Control (1994) 1.41
Can we skill and activate children through primary school physical education lessons? "Move it Groove it"--a collaborative health promotion intervention. Prev Med (2003) 1.37
Vimentin: an evaluation of its role as a tumour marker. Histopathology (1987) 1.36
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir. Antimicrob Agents Chemother (2001) 1.32
Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet (1991) 1.32
NADP, corepressor for the Bacillus catabolite control protein CcpA. Proc Natl Acad Sci U S A (1998) 1.28
Delayed presentation to clinics for sexually transmitted diseases by symptomatic patients. A potential contributor to continuing STD morbidity. Sex Transm Dis (1997) 1.27
Mucin secretion and striated muscle in the human thymus. Lancet (1966) 1.26
Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity. Mol Microbiol (2001) 1.26
Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthalmology (1989) 1.25
Effect of nasal continuous positive airway pressure on sleep apnea in congestive heart failure. Am Rev Respir Dis (1989) 1.25
Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis (1985) 1.22
Subepithelial collagen in intestinal malabsorption. Gut (1975) 1.22
A hierarchical model of domains of disablement in the elderly: a longitudinal approach. Disabil Rehabil (2000) 1.21
MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med (2003) 1.21
Concentration-controlled zidovudine therapy. Clin Pharmacol Ther (1998) 1.20
Smoking patterns among Chinese rural-urban migrant workers. Public Health (2009) 1.20
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Physiological determinants of nocturnal arterial oxygenation in patients with obstructive sleep apnea. J Appl Physiol (1985) (1985) 1.18
A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol (1985) 1.17
Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology (1981) 1.17
Remission of HIV myelopathy after highly active antiretroviral therapy. Neurology (2000) 1.17
Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol (2003) 1.17
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1999) 1.16
A new technique for examining intestinal biopsies. Gut (1973) 1.16
Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir. AIDS (1999) 1.15
The DosR regulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb) (2009) 1.15
Bone marrow transplantation for severe aplastic anaemia. A review of the Westminster experience of 24 cases. Clin Lab Haematol (1983) 1.14
The Mycobacterium tuberculosis sigma factor sigmaB is required for full response to cell envelope stress and hypoxia in vitro, but it is dispensable for in vivo growth. J Bacteriol (2009) 1.12
Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis (2010) 1.12
Do high functioning persons with autism present superior spatial abilities? Neuropsychologia (2004) 1.10
KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. Virchows Arch (1994) 1.09
Restoration of T-lymphocyte deficiency with dialysable leucocyte extract. Clin Exp Immunol (1974) 1.09
A new radiological classification for ameloblastoma based on analysis of 19 cases. West Indian Med J (2006) 1.06
Variations in dietary iron alter behavior in developing rats. J Nutr (2001) 1.06
Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients. Eur J Cancer (2002) 1.05
In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed (2002) 1.05
Abdominocervical (transhiatal) oesophagectomy in the management of oesophageal carcinoma. Br J Surg (1990) 1.04
[Human echinococcosis in Switzerland, 1984-1992]. Schweiz Med Wochenschr (1995) 1.04
Hypocapnia and increased ventilatory responsiveness in patients with idiopathic central sleep apnea. Am J Respir Crit Care Med (1995) 1.02
Alpha-chain disease with clinical, immunological, and histological recovery. Br Med J (1974) 1.02
Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid. Gut (1974) 1.02
Interleukin-6 and d-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection. HIV Med (2010) 1.00
Supercritical carbon dioxide extraction of selected medicinal plants--effects of high pressure and added ethanol on yield of extracted substances. Phytochem Anal (2004) 1.00
The thymus in rheumatic heart disease. Clin Exp Immunol (1968) 1.00
The effect of the erg26-1 mutation on the regulation of lipid metabolism in Saccharomyces cerevisiae. J Biol Chem (2001) 1.00
Reversal of sleep-induced hypoventilation and chronic respiratory failure by nocturnal negative pressure ventilation in patients with restrictive ventilatory impairment. Am Rev Respir Dis (1987) 1.00
The endovascular management of blue finger syndrome. Eur J Vasc Endovasc Surg (1999) 0.99
SWIFT: prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen. Clin Infect Dis (2013) 0.99
Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology (2006) 0.99
Recovery and analysis of human immunodeficiency virus type 1 (HIV) RNA sequences from plasma samples with low HIV RNA levels. J Clin Microbiol (2000) 0.99
Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma. Histopathology (1986) 0.98
Program sustainability of a community-based intervention to prevent falls among older Australians. Health Promot Int (2004) 0.98
Effects of inhaled CO2 and added dead space on idiopathic central sleep apnea. J Appl Physiol (1985) (1997) 0.97
Effect of continuous positive airway pressure on central sleep apnea and nocturnal PCO2 in heart failure. Am J Respir Crit Care Med (1994) 0.97
Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin Exp Immunol (2013) 0.97
Pulmonary blastoma with a striated muscle component. Br J Dis Chest (1966) 0.96
Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6. J Clin Pathol (2001) 0.96
Electron microscopy in the non-Hodgkin's lymphomata. Br J Cancer Suppl (1975) 0.96